RBC Capital Reiterates Outperform on Mondelez Int'l (MDLZ) Following In-Line 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Hershey sees squeeze from growing U.S. income gap
October 28, 2015 5:41 PM EDTBy Anjali Athavaley
NEW YORK (Reuters) - Chocolate maker Hershey Co (NYSE: HSY), long a staple of middle-class U.S. households, is getting squeezed as consumers either pay up for fancier sweets or seek more savings. The maker of Hershey kisses and Reeses peanut butter cups reported lower-than-expected U.S. sales on Wednesday and cut its profit forecast for the year, sending shares down 6.5 percent. It has cut such forecasts for five quarters in a row.
Hershey executives said the company is grappling with a growing gap between low and high-income... More
Mondelez Int'l (MDLZ) Tops Q3 EPS by 1c, Reaffirms Outlook
October 28, 2015 8:04 AM EDTMondelez Int'l (NASDAQ: MDLZ) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $6.85 million versus the consensus estimate of $6.81... More
Pre-Open Stock Movers 10/27: (TRIV) (UQM) (BABA) Higher; (RRTS) (RCII) (MRVL) Lower (more...)
October 27, 2015 9:31 AM EDTTriVascular Technologies, Inc. (Nasdaq: TRIV) 50.8% HIGHER; Endologix (NASDAQ: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at $9.10 per TriVascular share, or a total of approximately $211 million, based on Endologix's closing stock price of $13.81 per share on October 23, 2015.
Roadrunner Transportation (NYSE:... More
